Nayax 2025: The Bond Market Reopened, but How Much Covenant Room Is Really Left
Nayax's 2025 note offerings did mark a real reopening of the local debt market, moving from an initial issue at a discount to a December expansion at a premium. But year-end equity-to-assets still stood at only 27.1%, and a meaningful part of the cushion came from the warrant structure recognized in equity, not only from capital built through operations.
The Bond Market Really Reopened, but That Is Not the Same Thing as Wide Capital Room
The main article already made the broader point: Nayax entered 2026 with a stronger recurring engine, but the real test had shifted to capital quality, cash quality, and credit discipline. This follow-up isolates one financing thread inside that thesis. The key question is not whether Nayax managed to issue debt in 2025. The key question is what that reopening actually bought.
The answer has two layers. Yes, the local market clearly improved its pricing. In March 2025 Nayax sold 486,291 units at NIS 1,021 per unit and raised about NIS 496.5 million gross. In December 2025 it expanded the same series, sold 518,381 units at NIS 1,091 per unit, and raised about NIS 565.5 million gross. In plain terms, the December expansion came at a higher unit price and with larger proceeds.
But that is only one layer. The other layer is structure. In both offerings, each unit was not straight debt. It included NIS 1,000 principal amount of Series A notes plus three warrants. In March, NIS 20.7 million of proceeds was allocated to the warrants and recognized in equity. In December, another NIS 34.9 million was allocated the same way. Together that is NIS 55.6 million, or about $16.5 million, added to the accounting equity cushion through the warrant layer. Anyone reading the reopened market as pure debt access is missing the core point. Part of the covenant room was created because investors also received equity-linked optionality.
Even the Discount Figure Shows a Cleaner Market
The immediate report on the weighted discount rate shows just how different December was from March. The first issuance carried a 0.86% discount rate. The December expansion was completed at a 1.029% premium. The weighted discount rate for the full series was then updated to 0.45%.
That 0.45% figure needs to be read carefully. It looks like only a partial improvement, but the calculation mechanism does not count the December premium as a negative discount. It simply clips that tranche to zero. In other words, once Nayax managed to expand the series at a premium, the economic improvement was actually sharper than the weighted figure suggests.
That technical detail matters because it changes the read. Market access genuinely improved. This was not only about more demand or more volume. By December, the market was willing to fund Nayax on terms that were clearly better for the issuer than in March.
But the Covenant Cushion Is Still Moderate, Not Wide
That leads to the more important question: how much room was really left after all of this. At year-end 2025, equity stood at $231.0 million and total assets at $852.6 million. The equity-to-assets ratio therefore stood at 27.1%.
Against the base covenant threshold of 21%, that looks comfortable. Nayax was 6.1 percentage points above the line, or about $52.0 million of equity above the minimum level implied by that ratio. The $80 million minimum equity covenant was also far away, with roughly $151 million of headroom. If that were the full story, it would be easy to conclude that the financing question had largely moved behind the company.
But that is not the right threshold for judging real capital room. The more important line is 29%, because that is the ratio the company needs, together with equity above $120 million, in order to permit dividends or buybacks. Here the picture is much tighter. Nayax ended 2025 at 27.1%, still 1.9 percentage points below that line, or short by about $16.3 million of equity relative to the level needed to cross it.
That is the sharpest insight in the whole thread. The binding issue is no longer the absolute equity amount. $231.0 million is comfortably above both the $80 million floor and the $120 million distribution gate. The real constraint is the denominator. Total assets jumped to $852.6 million from $432.9 million a year earlier, so even after a profitable year and two successful offerings, the ratio still did not fully open up.
| Metric | Year-end 2025 | What it means |
|---|---|---|
| Equity | $231.0 million | Well above both the $80 million and $120 million equity tests |
| Total assets | $852.6 million | The denominator almost doubled versus 2024 |
| Equity-to-assets ratio | 27.1% | Comfortable versus 21%, but still below 29% |
| Headroom above 21% | $52.0 million | Enough for basic covenant comfort |
| Shortfall to 29% | $16.3 million | The door to distributions is still closed |
| Warrant allocation recognized in equity | $16.5 million | Part of the cushion came from deal structure, not only from retained capital |
The Warrants Bought Cushion, but They Did Not Solve the Problem
This is the core of the continuation thesis. If the $16.5 million allocated to the warrants in March and December is stripped out of year-end equity, the equity-to-assets ratio falls to roughly 25.2%. In that case, the shortfall to the 29% distribution threshold jumps to about $32.8 million, almost double the actual gap.
So yes, the reopened bond market did create covenant room. But that room was not built entirely in the classic way, through retained earnings, cleaner cash generation, and a structurally lighter balance sheet. A meaningful part of it was built through a warrant package that qualifies for equity classification. That is legitimate and smart deal design. It is just not the same type of cushion.
A cushion built through retained earnings can absorb continued growth, acquisitions, or working-capital expansion without depending on a later market decision. A cushion born through equity-classified warrants helps immediately in the reported capital structure, but it only turns into full cash equity if those warrants are actually exercised. As of December 31, 2025, that had not happened yet. That is why 27.1% should not be read as if all of that room is equally hard.
There is another important implication here. The 2025 offerings gave Nayax flexibility to finance growth, acquisitions, and debt layering. They did not yet give it full capital-allocation freedom. The company can raise. It is still not truly distribution-ready.
What Has to Happen Next
From here, the focus of the story changes. The near-term question is not really whether Nayax can stay above 21%. Based on year-end numbers, that line looks reasonably safe. The more interesting question is whether the company can build equity faster than the balance sheet keeps expanding.
That can happen in three ways. First, net profit can stay inside the system and turn into equity without the denominator expanding at the same pace. Second, the warrants, which expire on March 31, 2027 and had an exercise price of NIS 155.5 per share at year-end 2025, can actually be exercised. Third, balance-sheet discipline can improve, meaning less asset growth for every dollar of new capital.
That is why the right reading of 2025 is not "the bond market reopened, so the financing issue is solved." The sharper reading is this: the bond market reopened, so immediate financing pressure fell. But the remaining covenant room is not wide enough to treat Nayax as a company with full capital freedom. As long as the ratio remains below 29%, the market has bought the company time and flexibility. It has not yet bought it free hands.
That is also why 2026 should be tracked less through the headline of market access and more through the quality of capital formation. If profit, cash, and equity start rising without the balance sheet expanding at the same pace, the 2025 reopening will look like a genuine turning point. If not, it will look more like a relatively comfortable bridge, but still a bridge.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.